- Companies
- Jianhai Technology
Jianhai Technology Funding, Investors & Competitors
Jianhai Technology has raised $125M across 4 funding rounds, most recently a $78M Series B in November 2021.
Last Jianhai Technology funding round
$78M
Series B · Nov 2021
Cumulative funding Jianhai Technology raised
$125M
across 4 funding rounds
Key investors in Jianhai Technology
Sherpa Healthcare Partners
HSG
Source Code Capital
iFlytek
Haibang Capital
Huasheng Capital
Panorama Capital
Sanzheng Health
Jianhai Technology Overview
About Jianhai Technology
Jianhai Technology is a Chinese AI platform providing whole-course management services for post-hospital and post-diagnosis care, supporting patient monitoring and health data analysis.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Services, Subscription
Jianhai Technology Funding History
Jianhai Technology has raised a total of $125M across 4 funding rounds.
Jianhai Technology's first fundraising round was a $15M Series A in July 2019. The most recent completed round was a $78M Series B in November 2021.
Jianhai Technology funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Nov 2021 | Series B | Huasheng Capital; Sherpa Healthcare Partners; Sanzheng Health; HSG; Panorama Capital | $78M | - |
| Mar 2021 | Series B | HSG (lead); Sherpa Healthcare Partners; Source Code Capital | $23M | Hangzhou Jianhai Technology Co., Ltd. develops digital health solutions focused on post-disease management, including digital therapy platforms that integrate with hospital workflows for patient engagement and care delivery. The company operates a B2B subscription-based model, partnering with over 1,000 hospitals to provide access to online doctor networks and disease management tools. Its offerings target streamlining post-discharge processes in traditional healthcare settings. A January 2022 Series B raised CNY 150 million led by Sequoia Capital with Sherpa and Source Code participation. The company plans fund use for R&D expansion, clinical trials, personnel, new products, and geographic growth. |
| Sep 2020 | Series A | Sherpa Healthcare Partners; Source Code Capital | $9M | - |
| Jul 2019 | Series A | Sherpa Healthcare Partners; iFlytek; Haibang Capital | $15M | - |
Who has invested in Jianhai Technology?
8 investors have backed Jianhai Technology across its funding rounds, including Sherpa Healthcare Partners, HSG, Source Code Capital, iFlytek, Haibang Capital and Huasheng Capital.
Lead investors include HSG.
Jianhai Technology Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Participant | Jul 2019 | ||
| 2 | Lead | Mar 2021 | ||
| 2 | Participant | Sep 2020 | ||
| 1 | Participant | Nov 2021 | ||
| 1 | Participant | Jul 2019 | ||
| -- | 1 | Participant | Nov 2021 | |
This data is available for Pro users. Sign up to see all 8 Jianhai Technology investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialJianhai Technology Competitors
Jianhai Technology competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $3.2B | $965M | $43B | 10.2x | ||
| Publicly listed | $4.3B | $1.5B | $40B | 8.9x | ||
| Publicly listed | $7.9B | $3.2B | $37B | 5.7x | ||
| Private | $200M | - | $7B | 35.0x | ||
| Private | $400M | - | $6.4B | 16.0x |
Jianhai Technology Public Comps
Jianhai Technology is still privately-owned, but its public comps include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging, Glaukos and M3 Inc..
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $8.3B | $816M | 1.9x | 1.9x | 19.2x | 11.3x | |||
| $186M | $147M | 66.6x | 62.7x | 84.4x | 77.6x | |||
| $2.1B | $367M | 5.5x | 4.8x | 30.7x | 26.9x | |||
This data is available for Pro users. Sign up to see all Jianhai Technology competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Jianhai Technology
| When was Jianhai Technology founded? | Jianhai Technology was founded in 2015. |
| Where is Jianhai Technology headquartered? | Jianhai Technology is headquartered in Hangzhou, China. |
| Is Jianhai Technology publicly listed? | No, Jianhai Technology is a private, VC-backed company. |
| How much funding has Jianhai Technology raised? | Jianhai Technology has raised $125M across 4 funding rounds. |
| What was Jianhai Technology's last funding round? | Jianhai Technology's last funding round was a $78M Series B in November 2021. |
| Who are Jianhai Technology's investors? | Jianhai Technology's investors include Sherpa Healthcare Partners, HSG, Source Code Capital, Huasheng Capital, iFlytek, Sanzheng Health, Haibang Capital and Panorama Capital. |
| Which companies are comparable to Jianhai Technology? | Companies comparable to Jianhai Technology include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib. |
See companies similar to Jianhai Technology
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




